BPC-157 improved early functional recovery of the Achilles tendon-to-bone unit after transection, and this improvement persisted even during concurrent methylprednisolone treatment that normally impairs healing.
Key findingBPC-157 improved early functional recovery (load-to-failure, stiffness) of transected Achilles tendon-to-bone unit, with efficacy maintained during co
What the researchers found
BPC-157 improved early functional recovery (load-to-failure, stiffness) of transected Achilles tendon-to-bone unit, with efficacy maintained during concurrent methylprednisolone — confirming dual tendon-healing and steroid-impairment-overcoming capabilities.
Why it matters
Relevant for bpc-157, muscle-recovery, bone-joint.
How the study worked
animal-study study.
What this study cannot tell us
See abstract.
How to read the evidence
preliminary evidence.
When this study was published
Published in 2008.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
Modulation of early functional recovery of Achilles tendon to bone unit after transection by BPC 157 and methylprednisolone.
Inflammation research : official journal of the European Histamine Research Society ... [et al.], 57(5), 205-10
Citation
Krivic, A; Majerovic, M; Jelic, I; Seiwerth, S; Sikiric, P. (2008). Modulation of early functional recovery of Achilles tendon to bone unit after transection by BPC 157 and methylprednisolone.. Inflammation research : official journal of the European Histamine Research Society ... [et al.], 57(5), 205-10. https://doi.org/10.1007/s00011-007-7056-8